Skip to main content

Table 1 Incidence of IPD (/100,000 population) in Western European countries

From: Pneumococcal serotype evolution in Western Europe

 

Pre-PCV7 period

Post-PCV7 period

Post-higher PCV period

Countries in which only PCV13 used

Belgium [11]

2002–2003

 

2013

<2 years

155.9

 

56.0

Denmark [14]

2000–2007

2008–2010

2011–2013

<2 years

55.1

25.9

16.0

≥65 years

65.5

60.0

49.4

France [20]

2001–2002

2008–2009

2012

<2 years

30.3

24.6

17.2

>64 years

27.7

31.1

26.5

Ireland [21]

2008

2011

2012

All ages

9.5

7.6

7.6

Norway [25]

2005

2010

2012

<2 years

77.0

20.0

8.1

All ages

23.0

15.0

13.0

Spain (Madrid) [27]

-

2007–2010

2011–2012

<15 years

-

17.1

7.7

Switzerland [29, 30]

2002–2005

2010

2012

<2 years

27.1

20.6

8.1

≥65 years

42.1

35.2

35.7

UK [31]

 

2008–2010

2013–2014

<2 years

-

22.2

12.0

≥65 years

-

27.6

20.6

Countries in which only PCV13 used

Finland [39]

2006

2010

2014

<1 year

68.5

50.7

11.2

>64 years

31.1

32.3

32.5

Countries in which both PCV13 and PCV10 used

Germany [42–44]

1997–2001

2010

2012

<2 yearsa

7.7

4.1

3.7

<2 yearsb

12.7

9.4

6.3

Spain (Navarra) [47]

2001–2003

2004–2009

2010–2013

<5 years

87.1

60.7

18.7

≥65 years

33.6

32.5

25.0

Portugal [48]

 

2008–2009

2011–2012

<1 year

-

52.1

25.1

1-2 years

-

31.6

16.1

  1. aPneumococcal meningitis: bpneumococcal non-meningitis IPD